Endocannabinoids New Targets for Drug Development

E-ISSN： 1873-4286|6|13|1361-1380

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.13, 2000-09, pp. : 1361-1380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Focus on the Three Key Enzymes Hydrolysing Endocannabinoids as New Drug Targets

Current Pharmaceutical Design, Vol. 11, Iss. 20, 2005-08 ,pp. : 2647-2668

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant therapy: new targets for drug development

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1693-1711

Informa Healthcare

Access to resources Recommend Favorite

The Pim Kinases: New Targets for Drug Development

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2059-2066

Bentham Science Publishers

Access to resources Recommend Favorite

Sulfated Oligosaccharides: New Targets for Drug Development?

Current Medicinal Chemistry, Vol. 16, Iss. 18, 2009-06 ,pp. : 2338-2344

Bentham Science Publishers

Access to resources Recommend Favorite

Development of New Antituberculous Drugs: Strategies for New Drug Targets and Drug Delivery

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 427-434

Bentham Science Publishers

Access to resources Recommend Favorite